Bioanalytical Systems, Inc. (BASi) and MicaGenix, Inc. have entered a contract research partnership for complementary preclinical research services for pharmaceutical, medical device and biotechnology companies, as well as for medical schools. MicaGenix focuses on mutagenicity work, histopathology services, and regulatory package preparation and review; BASi is a pharmaceutical development company providing contract research services generally downstream from MicaGenix in pharmacokinetics, pharm...